Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction
Status unconfirmed · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Osteoarthritis, Knee
In brief
This is a prospective, randomized, placebo-controlled trial to evaluate potential beneficial effects of leukocyte-poor platelet rich plasma and bone marrow concentrate on the healing and health of critical joint tissues in the knee following anterior cruciate ligament (ACL) reconstruction. Bone marrow contains stem cells which can change into cells of various different tissue types, while platelet rich plasma contains growth factors. This trial will compare the two procedures against placebo.
Key facts
- Study ID
- NCT04205656
- Run by
- Steadman Philippon Research Institute
- People needed
- 45
- Starts
- 2020-01-02
- Expected to finish
- 2024-09-01
- Last updated by the study team
- 2024-07-16
Who can join
Age: 16 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
Where it is running
- 181 West Meadow Drive, Suite 1000 — Vail, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.